- Sunshine Biopharma (NASDAQ:SBFM) received a 180-day extension, until March 18, 2024, to achieve compliance with the Nasdaq $1.00 minimum bid price rule.
- If at any time before March 18, 2024, the closing bid price of the company's common stock is at least $1.00 per share for a minimum of 10 consecutive business days, the company will regain compliance with this Nasdaq rule and this matter will be closed.
- Source: Press Release
Sunshine Biopharma gets 180-day extension to achieve Nasdaq compliance
Recommended For You
More Trending News
About SBFM Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| SBFM | - | - |
| Sunshine Biopharma, Inc. | ||